39.15
-0.06 (-0.15%)
-0.06 (-0.15%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Royalty Pharma PLC | RPRX | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.06 | -0.15% | 39.15 | 20:00:00 |
| Close Price | Low Price | High Price | Open Price | Previous Close |
|---|---|---|---|---|
| 39.01 | 38.80 | 40.10 | 39.49 | 39.21 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 39.03 | 42.80 | 3.77 | - | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 8,474 | 876,122 | $ 39.19 | $ 34,333,538 | 1,639,737 | 38.10 - 57.50 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:46:43 | 2 | $ 39.15 | USD |
Royalty Pharma Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 23.77B | 607.11M | 263.46M | $ 1.79B | $ - | 3.35 | 19.80 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 153.02% | 57.56k | - |
Royalty Pharma News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical RPRX Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 44.25 | 44.49 | 38.10 | 40.45 | 3,824,973 | -5.10 | -11.53% |
| 1 Month | 40.00 | 44.97 | 38.10 | 41.53 | 1,612,593 | -0.85 | -2.13% |
| 3 Months | 42.86 | 47.15 | 38.10 | 41.85 | 1,221,987 | -3.71 | -8.66% |
| 6 Months | 45.90 | 57.50 | 38.10 | 44.61 | 1,540,586 | -6.75 | -14.71% |
| 1 Year | 45.90 | 57.50 | 38.10 | 44.61 | 1,540,586 | -6.75 | -14.71% |
| 3 Years | 0.5678 | 57.50 | 0.3619 | 32.59 | 1,216,642 | 38.58 | 6,795.03% |
| 5 Years | 5.38 | 57.50 | 0.26 | 12.00 | 890,174 | 33.77 | 627.7% |
Royalty Pharma Description
| Royalty Pharma PLC is a buyer of biopharmaceutical royalties and a funder of innovation across the biopharmaceutical industry. The company's portfolio consists of royalties on more than 45 marketed therapies and four development-stage product candidates. The therapies in portfolio address therapeutic areas such as rare diseases, oncology, neurology, HIV, cardiology and diabetes, and are delivered to patients across both primary and specialty care settings. |
